We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

125 hedge funds and large institutions have $4.23B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 28

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

43% more call options, than puts

Call options by funds: $21.3M | Put options by funds: $14.9M

12% more capital invested

Capital invested by funds: $3.78B → $4.23B (+$443M)

10% more funds holding

Funds holding: 114 → 125 (+11)

Holders
125
Holders Change
+11
Holders Change %
+9.65%
% of All Funds
2.01%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
25
Increased
54
Reduced
28
Closed
14
Calls
$21.3M
Puts
$14.9M
Net Calls
+$6.4M
Net Calls Change
+$2.78M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$19.9M
2
Barclays
Barclays
United Kingdom
+$10.1M
3
BlackRock
BlackRock
New York
+$8.29M
4
LGM
Logos Global Management
California
+$7.34M
5
American Century Companies
American Century Companies
Missouri
+$7.09M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$45.6M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$19.2M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$12.6M
4
IC
Ikarian Capital
Texas
-$5.03M
5
Alkeon Capital Management
Alkeon Capital Management
New York
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
76
Schonfeld Strategic Advisors
New York
$486K +$435K +15,400 New
SG Americas Securities
77
SG Americas Securities
New York
$457K +$121K +4,271 +42%
State Board of Administration of Florida Retirement System
78
State Board of Administration of Florida Retirement System
Florida
$444K +$10.2K +360 +3%
PVI
79
Pura Vida Investments
New York
$442K -$766K -27,136 -66%
Public Employees Retirement Association of Colorado
80
Public Employees Retirement Association of Colorado
Colorado
$433K – – –
YIH
81
Y-Intercept (HK)
Hong Kong
$426K +$381K +13,491 New
EFM
82
E Fund Management
China
$395K +$59.5K +2,109 +20%
EMG
83
ETF Managers Group
New Jersey
$357K +$319K +11,313 New
GC
84
Guggenheim Capital
Illinois
$331K +$296K +10,494 New
Zurich Cantonal Bank
85
Zurich Cantonal Bank
Switzerland
$320K +$85.2K +3,020 +42%
Lazard Asset Management
86
Lazard Asset Management
New York
$320K +$287K +10,158 New
AB
87
Amalgamated Bank
New York
$301K +$23.5K +834 +10%
Jane Street
88
Jane Street
New York
$300K +$269K +9,521 New
Handelsbanken Fonder
89
Handelsbanken Fonder
Sweden
$284K – – –
QT
90
Quantbot Technologies
New York
$273K +$244K +8,647 New
Royal Bank of Canada
91
Royal Bank of Canada
Ontario, Canada
$257K +$146K +5,191 +175%
ACM
92
Aquatic Capital Management
Illinois
$257K +$231K +8,200 New
Two Sigma Investments
93
Two Sigma Investments
New York
$252K +$226K +8,000 New
Victory Capital Management
94
Victory Capital Management
Texas
$240K -$288K -10,192 -57%
PAMS
95
Pictet Asset Management (Switzerland)
Switzerland
$239K +$214K +7,577 New
ProShare Advisors
96
ProShare Advisors
Maryland
$233K +$208K +7,372 New
Franklin Resources
97
Franklin Resources
California
$209K +$187K +6,613 New
CSS
98
Cubist Systematic Strategies
Connecticut
$192K -$765K -27,122 -82%
VEA
99
Virtus ETF Advisers
New York
$164K +$25.8K +916 +21%
AIP
100
Ameritas Investment Partners
Nebraska
$149K +$14.3K +508 +12%
2 3
4
5 6

CERE Hedge Fund Activity: Q4 2022 in Review

125 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q4 2022, worth a combined $4.23B — up 12% from $3.78B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new CERE positions and 14 closed out — a net gain of 11 holders — while 54 added to existing stakes and 28 trimmed.

The largest buyer was State Street, adding an estimated $19.9M. The largest seller was Janus Henderson Group, cutting an estimated $45.6M.

  • 125 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q4 2022, up from 114 in Q3 2022.
  • Funds reported $4.23B of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q4 2022, up 12% quarter-over-quarter.
  • 25 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q4 2022 and 14 closed out, a net change of +11 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q4 2022 was State Street, an estimated $19.9M added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q4 2022 was Janus Henderson Group, an estimated $45.6M sold.

Based on aggregated 13F filings for Q4 2022.